Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36858722

Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2023 Mar
First author
Mauz-Körholz C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Mar;24(3):196-197. doi: 10.1016/S1470-2045(23)00058-X.
    note
    Source null
    related pmid
    36858717
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2023 Jun;24(6):e230. doi: 10.1016/S1470-2045(23)00211-5.
    note
    Source null
    related pmid
    37269848
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2023 Jun;24(6):e231. doi: 10.1016/S1470-2045(23)00235-8.
    note
    Source null
    related pmid
    37269849
    relationship
    Comment in

Authors and identifiers

  1. name
    Mauz-Körholz C
    type
    Author
  2. name
    Landman-Parker J
    type
    Author
  3. name
    Fernández-Teijeiro A
    type
    Author
  4. name
    Attarbaschi A
    type
    Author
  5. name
    Balwierz W
    type
    Author
  6. name
    Bartelt JM
    type
    Author
  7. name
    Beishuizen A
    type
    Author
  8. name
    Boudjemaa S
    type
    Author
  9. name
    Cepelova M
    type
    Author
  10. name
    Ceppi F
    type
    Author
  11. name
    Claviez A
    type
    Author
  12. name
    Daw S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mauz-Körholz C
    type
    Author
  2. name
    Landman-Parker J
    type
    Author
  3. name
    Fernández-Teijeiro A
    type
    Author
  4. name
    Attarbaschi A
    type
    Author
  5. name
    Balwierz W
    type
    Author
  6. name
    Bartelt JM
    type
    Author
  7. name
    Beishuizen A
    type
    Author
  8. name
    Boudjemaa S
    type
    Author
  9. name
    Cepelova M
    type
    Author
  10. name
    Ceppi F
    type
    Author
  11. name
    Claviez A
    type
    Author
  12. name
    Daw S
    type
    Author
bibliography ids
  1. nci-bib-7f323501af2adfdab8e2c712
book metadata
content sha256
b6d7814210cab72640dbaf00ecfe3f120ffa59e0416f6d936e36096043f696fa
document type
citation
dois
  1. 10.1016/S1470-2045(23)00019-0
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:36858722
immutable id
pubmed:36858722@b6d7814210cab72640dbaf00ecfe3f120ffa59e0416f6d936e36096043f696fa
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
252-261
volume
24
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Mar;24(3):196-197. doi: 10.1016/S1470-2045(23)00058-X.
    note
    Source null
    related pmid
    36858717
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2023 Jun;24(6):e230. doi: 10.1016/S1470-2045(23)00211-5.
    note
    Source null
    related pmid
    37269848
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2023 Jun;24(6):e231. doi: 10.1016/S1470-2045(23)00235-8.
    note
    Source null
    related pmid
    37269849
    relationship
    Comment in
outcomes validated
false
pmid
36858722
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
8e37e51030e7af1702a2b5f2079646de81c08de7d4829535a0a67ba1978a4668
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Mar
precision
month
year
2023
publication types
  1. Clinical Trial
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36858722/
title
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.

Preserved source evidence · Not medical advice